The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Status epilepticus in a patient treated with olanzapine and mirtazapine.

TitleStatus epilepticus in a patient treated with olanzapine and mirtazapine.
Publication TypeJournal Article
Year of Publication2009
AuthorsSpyridi, S., Sokolaki S., Nimatoudis J., Iacovides A., & Kaprinis G.
JournalInt J Clin Pharmacol Ther
Volume47
Issue2
Pagination120-3
Date Published2009 Feb
ISSN0946-1965
KeywordsAntidepressive Agents, Tricyclic, Antipsychotic Agents, Benzodiazepines, Drug Interactions, Female, Humans, Mianserin, Middle Aged, Psychotic Disorders, Status Epilepticus
Abstract

OBJECTIVE: Few cases of seizures associated with olanzapine therapy and even fewer with mirtazapine have been published, most of them in patients with confounding risk factors. Our objective was to report a case of Status epilepticus in a patient receiving olanzapine and mirtazapine, with no previous history of seizure and no confirmed underlying cause for seizure.CASE SUMMARY: A 48-year-old white, psychotic woman developed generalized tonic-clonic seizures that progressed to Status epilepticus during hospitalization. 4 days before the incident, mirtazapine (30 mg) was added to the treatment, while 2 days before the incident, the treatment switched from quetiapine to olanzapine, and mirtazapine was increased to 60 mg. No other toxic, metabolic, electrolyte or anatomic abnormality was identified. After discontinuation of olanzapine, the patient remained seizure-free.CONCLUSION: To our knowledge, this is the second reported case of Status epilepticus that has been associated with the use of olanzapine, while only one report of seizures, but none of Status epilepticus connected to mirtazapine is found in the literature. Although olanzapine has infrequently been associated with epileptogenic risk, it should be used cautiously especially when concomitant medication or other predisposing factors exist.

Alternate JournalInt J Clin Pharmacol Ther
PubMed ID19203568

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.